http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115093406-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f7031a0a7df6f5148e9d259240dd21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40808e600194fc5b4cce5611dea086c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 2022-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebfe0d4d600ec30d8eb2add414a5f1cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3cd6629a715e9936e41ad15a04769a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a74952aeadf0cf662adcd30514ae971f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09ff3964d5dc18ce175b0087a9f775d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a238f95f8aff9ea7cf40880555d8e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a201f1394bb84c731b6e2414cc1cdc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9157936dd824579ce5fca0cdb4288cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3ddf692b5ac834d37ed3f1132476b3
publicationDate 2022-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115093406-A
titleOfInvention A selective KCNQ channel opener and its application in pharmacy
abstract The invention discloses a KCNQ2/3 potassium ion channel selective regulator compound A, which has high opening activity and high selectivity for KCNQ2/3 channels, but has no opening activity for KCNQ1, KCNQ4 and KCNQ5. In view of the fact that the compound A provided by the present invention is a highly active and highly selective KCNQ2/3 channel opener, the present invention also proposes that it can be used in pharmaceutical preparations for the preparation of antiepileptic drugs, analgesics, antidepressants, and for the treatment of ischemic Stroke disease drug application.
priorityDate 2022-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID568646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9132
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135562
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16509
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID226922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21866152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571630
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420243493
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID298496
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274

Total number of triples: 47.